1.           Introduction

1.1          Scope of the Study

1.2          The Insight Partners Research Report Guidance

1.3          Market Segmentation

1.3.1          South and Central America Carbapenem-based Antibiotics Market – By Type

1.3.2          South and Central America Carbapenem-based Antibiotics Market – By Indication

1.3.3          South and Central America Carbapenem-based Antibiotics Market – By Distribution Channel

1.3.4          South and Central America Carbapenem-based Antibiotics Market – By Country

2.           Carbapenem-based Antibiotics Market – Key Takeaways

3.        Research Methodology

3.1          Coverage

3.2          Secondary Research

3.3          Primary Research

4.           South and Central America Carbapenem-based Antibiotics Market – Market Landscape

4.1          Overview

4.2          PEST Analysis

4.2.1          South and Central America– PEST Analysis

4.3          Expert Opinions

5.           Carbapenem-based Antibiotics Market – Key Market Dynamics

5.1          Drivers

5.1.1          Rising Prevalence of Gram-Negative Bacterial Infections

5.1.2          Increasing Production of Generic Drugs

5.2          Market Restraints

5.2.1          Tedious and Expensive Process of Antibiotic Development

5.3          Market Opportunities

5.3.1          Private and Public Partnerships

5.4          Future Trends

5.4.1          Strategic Advancement for New Antibiotic Identification

5.5          Impact Analysis

6.           Carbapenem-based Antibiotics Market –South and Central America Analysis

6.1          South and Central America Carbapenem-based Antibiotics Market Revenue Forecast and Analysis

7.           Carbapenem-based Antibiotics Market Analysis – By Type

7.1          Overview

7.2          Carbapenem-based Antibiotics Market Revenue Share, by Type (2021 and 2028)

7.3          Meropenem

7.3.1          Overview

7.3.2          Meropenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.4          Doripenem

7.4.1          Overview

7.4.2          Doripenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.5          Imipenem

7.5.1          Overview

7.5.2          Imipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.6          Tebipenem

7.6.1          Overview

7.6.2          Tebipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

7.7          Others

7.7.1          Overview

7.7.2          Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.           Carbapenem-based Antibiotics Market – By Indication

8.1          Overview

8.2          Carbapenem-based Antibiotics Market, by Indication, 2021 and 2028 (%)

8.3          Bacterial Meningitis

8.3.1          Overview

8.3.2          Bacterial Meningitis: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.4          Acute Pelvic Infections

8.4.1          Overview

8.4.2          Acute Pelvic Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.5          Respiratory Tract Infections

8.5.1          Overview

8.5.2          Respiratory Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.6          Intra-abdominal Infections

8.6.1          Overview

8.6.2          Intra-abdominal Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.7          Urinary Tract Infections

8.7.1          Overview

8.7.2          Urinary Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

8.8          Others

8.8.1          Overview

8.8.2          Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

9.           Carbapenem-based Antibiotics Market – By Distribution Channel

9.1          Overview

9.2          Carbapenem-based Antibiotics Market, by Distribution Channel, 2021 and 2028 (%)

9.3          Retail Pharmacies

9.3.1          Overview

9.3.2          Retail Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

9.4          Online Pharmacies

9.4.1          Overview

9.4.2          Online Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

9.5          Hospital Pharmacies

9.5.1          Overview

9.5.2          Hospital Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

10.        Carbapenem-based Antibiotics Market –Country Analysis

10.1        South and Central America: Carbapenem-based Antibiotics Market

10.1.1        Overview

10.1.2        South and Central America: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.3        South and Central America: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.4        South and Central America: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ Million)

10.1.5        South and Central America: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ Million)

10.1.6        South and Central America: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)

10.1.6.1          Brazil: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.1.1           Brazil: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.1.2           Brazil: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.1.3           Brazil: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.1.4           Brazil: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.1.6.2          Argentina: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.2.1           Argentina: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.2.2           Argentina: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.2.3           Argentina: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.2.4           Argentina: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

10.1.6.3          Rest of South and Central America: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.3.1           Rest of South and Central America: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

10.1.6.3.2           Rest of South and Central America: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)

10.1.6.3.3           Rest of South and Central America: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)

10.1.6.3.4           Rest of South and Central America: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)

11.        Impact of COVID-19 Pandemic on Carbapenem-based Antibiotics Market

11.1        South and Central America: Impact Assessment of COVID-19 Pandemic

12.        Carbapenem-based Antibiotics Market–Industry Landscape

12.1        Overview

12.2        Organic Developments

12.2.1        Overview

12.3        Inorganic Developments

12.3.1        Overview

13.        COMPANY PROFILES

13.1        ACS Dobfar S.p.A

13.1.1        Key Facts

13.1.2        Business Description

13.1.3        Products and Services

13.1.4        Financial Overview

13.1.5        SWOT Analysis

13.1.6        Key Developments

13.2        Gland Pharma Limited

13.2.1        Key Facts

13.2.2        Business Description

13.2.3        Products and Services

13.2.4        Financial Overview

13.2.5        SWOT Analysis

13.2.6        Key Developments

13.3        Merck & Co., Inc.

13.3.1        Key Facts

13.3.2        Business Description

13.3.3        Products and Services

13.3.4        Financial Overview

13.3.5        SWOT Analysis

13.3.6        Key Developments

13.4        Savior Lifetec

13.4.1        Key Facts

13.4.2        Business Description

13.4.3        Products and Services

13.4.4        Financial Overview

13.4.5        SWOT Analysis

13.4.6        Key Developments

13.5        Pfizer Inc.

13.5.1        Key Facts

13.5.2        Business Description

13.5.3        Products and Services

13.5.4        Financial Overview

13.5.5        SWOT Analysis

13.5.6        Key Developments

13.6        Spero Therapeutics

13.6.1        Key Facts

13.6.2        Business Description

13.6.3        Products and Services

13.6.4        Financial Overview

13.6.5        SWOT Analysis

13.6.6        Key Developments

14.        Appendix

14.1        About The Insight Partners

14.2        Glossary of Terms

LIST OF TABLES

Table 1.              South and Central America: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 2.              South and Central America: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)

Table 3.              South and Central America: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)

Table 4.              Brazil: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 5.              Brazil: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 6.              Brazil: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 7.              Argentina: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 8.              Argentina: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 9.              Argentina: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 10.            Rest of South and Central America: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)

Table 11.            Rest of South and Central America: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)

Table 12.            Rest of South and Central America: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)

Table 13.            Organic Developments in the Carbapenem-based Antibiotics Market

Table 14.            Inorganic Developments in the Carbapenem-based Antibiotics Market

Table 15.            Glossary of Terms, Carbapenem-based Antibiotics Market

LIST OF FIGURES

Figure 1.            Carbapenem-based Antibiotics Market Segmentation

Figure 2.            Carbapenem-based Antibiotics Segmentation, By Country

Figure 3.            South and Central America Carbapenem-based Antibiotics Market Overview

Figure 4.            The Others Segment Held Largest Share of Type Segment in Carbapenem-based Antibiotics Market

Figure 5.            South and Central America Carbapenem-based Antibiotics Market- Leading Country Markets (US$ Million)

Figure 6.            South and Central America PEST Analysis

Figure 7.            Carbapenem-based Antibiotics Market Impact Analysis of Driver and Restraints

Figure 8.            South and Central America Carbapenem-based Antibiotics Market – Revenue Forecast and Analysis – 2021- 2028

Figure 9.            Carbapenem-based Antibiotics Market Revenue Share, by Type (2021 and 2028)

Figure 10.          Meropenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11.          Doripenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.          Imipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.          Tebipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.          Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.          Carbapenem-based Antibiotics Market, by Indication, 2021 and 2028 (%)

Figure 16.          Bacterial Meningitis: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.          Acute Pelvic Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.          Respiratory Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.          Intra-abdominal Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.          Urinary Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.          Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.          Carbapenem-based Antibiotics Market, by Distribution Channel, 2021 and 2028 (%)

Figure 23.          Retail Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.          Online Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.          Hospital Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.          South and Central America: Carbapenem-based Antibiotics Market, by Key Country – Revenue (2021) (US$ ‘Million)

Figure 27.          South and Central America: Carbapenem-based Antibiotics Market Revenue and Forecast to 2028 (US$ ‘Million)

Figure 28.          South and Central America: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)

Figure 29.          Brazil: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 30.          Argentina: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 31.          Rest of South and Central America: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)

Figure 32.          Impact Of COVID-19 Pandemic in South and Central America Country Markets